title: Dermatomyositis and Graves' disease.
authors.forename: A
authors.initials: A
authors.lastname: Selva-O'Callaghan
authors.forename: T
authors.initials: T
authors.lastname: Mijares-Boeckh-Behrens
authors.forename: R
authors.initials: R
authors.lastname: Solans-Laque
authors.forename: T
authors.initials: T
authors.lastname: Molins-Vara
authors.forename: G
authors.initials: G
authors.lastname: Olivé
authors.forename: M
authors.initials: M
authors.lastname: Vilardell-Tarrés
mesh_terms: D013956:Antithyroid Agents / Q000627:therapeutic use; D001262:Atenolol / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D003882:Dermatomyositis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006111:Graves Disease / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D008713:Methimazole / Q000627:therapeutic use; D008875:Middle Aged; D013960:Thyroid Function Tests
chemical_list: D013956:Antithyroid Agents; D003879:Dermatologic Agents; D005938:Glucocorticoids; D006886:Hydroxychloroquine; D001262:Atenolol; D008713:Methimazole